John Kuelper is a Director at Ascension Ventures, a strategic venture capital and growth equity firm with over $800 million under management. Ascension invests in health IT, health services, medical devices, and diagnostics on behalf of 13 of the nation's largest nonprofit health systems. John focuses on investments in data-intensive software solutions that serve healthcare providers and consumers.
John is Founder and President of Qualia Holdings LLC, a platform for systems biology and software ventures. He has advised or worked for several investment firms (Adams Street Partners, Sterling Partners, Abundant Venture Partners), medical technology companies (Stereotaxis, Orpheden Therapeutics), and non-profits (Kresge Foundation, Blue Cross and Blue Shield Association). John began his career as a medical researcher studying computational neuroscience and medical robotics and has over 15 years of experience as a commercial software developer.
Education, Personal, and Fellowship
John earned a JD and an MBA from Northwestern University's Pritzker School of Law and the Kellogg School of Management, respectively. He earned his MBA with Honors and was elected Beta Gamma Sigma (top 10% of class). He earned a BA in cognitive neuroscience from Washington University, graduating magna cum laude.
John is a member of Class 19 and served his fellowship at Ascension Ventures under the mentorship of Managing Director Ryan Schuler.